Compare QNCX & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | TGHL |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | United States | Singapore |
| Employees | N/A | 7 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5M | 20.4M |
| IPO Year | 2019 | N/A |
| Metric | QNCX | TGHL |
|---|---|---|
| Price | $30.93 | $1.02 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.0K | ★ 7.6M |
| Earning Date | 04-10-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.27 |
| 52 Week High | $30.77 | $3.80 |
| Indicator | QNCX | TGHL |
|---|---|---|
| Relative Strength Index (RSI) | 92.46 | 57.66 |
| Support Level | $0.89 | $0.33 |
| Resistance Level | N/A | $1.35 |
| Average True Range (ATR) | 2.04 | 0.15 |
| MACD | 0.58 | 0.01 |
| Stochastic Oscillator | 96.56 | 56.70 |
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
The Growhub Ltd operates as the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, the company has developed a multi-faceted approach to address industry challenges. Its business currently comprises two main divisions, which are the Traceability and Authenticity Solutions and Carbon Project Development.